Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Vydra J, Válková V, Čemusová B, Kolář M, Nováková L, Soukup P, Šálek C, Vraná M, Pytlík R, Lesný P, Vítek A, Cetkovský P, Marková M.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):365-371. doi: 10.1016/j.clml.2019.02.005. Epub 2019 Feb 20.

PMID:
30905537
2.

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.

Kuželová K, Brodská B, Schetelig J, Röllig C, Ráčil Z, Walz JS, Helbig G, Fuchs O, Vraná M, Pecherková P, Šálek C, Mayer J.

PLoS One. 2018 Dec 17;13(12):e0204290. doi: 10.1371/journal.pone.0204290. eCollection 2018.

3.

Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies.

Xu M, Saxena N, Vrana M, Zhang H, Kumar V, Billington S, Khojasteh C, Heyward S, Unadkat JD, Prasad B.

Anal Chem. 2018 Oct 16;90(20):11873-11882. doi: 10.1021/acs.analchem.8b01913. Epub 2018 Sep 28.

PMID:
30204418
4.

Estrogen Promotes Mandibular Condylar Fibrocartilage Chondrogenesis and Inhibits Degeneration via Estrogen Receptor Alpha in Female Mice.

Robinson JL, Soria P, Xu M, Vrana M, Luchetti J, Lu HH, Chen J, Wadhwa S.

Sci Rep. 2018 Jun 4;8(1):8527. doi: 10.1038/s41598-018-26937-w.

5.

Distribution of HLA-DQB1 in Czech Patients with Central Hypersomnias.

Vrana M, Siffnerova V, Pecherkova P, Ratajova E, Sonka K.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):89-98. doi: 10.1007/s00005-016-0435-5. Epub 2017 Jan 12.

PMID:
28083611
6.

Database of Optimized Proteomic Quantitative Methods for Human Drug Disposition-Related Proteins for Applications in Physiologically Based Pharmacokinetic Modeling.

Vrana M, Whittington D, Nautiyal V, Prasad B.

CPT Pharmacometrics Syst Pharmacol. 2017 Apr;6(4):267-276. doi: 10.1002/psp4.12170. Epub 2017 Apr 4.

7.

The Promises of Quantitative Proteomics in Precision Medicine.

Prasad B, Vrana M, Mehrotra A, Johnson K, Bhatt DK.

J Pharm Sci. 2017 Mar;106(3):738-744. doi: 10.1016/j.xphs.2016.11.017. Epub 2016 Dec 8.

8.

Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.

Boberg M, Vrana M, Mehrotra A, Pearce RE, Gaedigk A, Bhatt DK, Leeder JS, Prasad B.

Drug Metab Dispos. 2017 Feb;45(2):216-223. doi: 10.1124/dmd.116.072652. Epub 2016 Nov 28.

9.

An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics.

Vrana M, Goodling A, Afkarian M, Prasad B.

Drug Metab Dispos. 2016 Oct;44(10):1692-6. doi: 10.1124/dmd.116.071522. Epub 2016 Aug 1.

10.

Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.

Prasad B, Gaedigk A, Vrana M, Gaedigk R, Leeder JS, Salphati L, Chu X, Xiao G, Hop C, Evers R, Gan L, Unadkat JD.

Clin Pharmacol Ther. 2016 Oct;100(4):362-70. doi: 10.1002/cpt.409. Epub 2016 Aug 13.

11.

A novel HLA-B allele, HLA-B*35:279, identified by sequencing-based typing in a Czech patient.

Mrazek F, Onderkova J, Königova N, Siffnerova V, Vrana M, Ambruzova Z, Skoumalova I, Petrek M, Raida L.

Int J Immunogenet. 2016 Aug;43(4):246-8. doi: 10.1111/iji.12276. Epub 2016 Jun 8.

PMID:
27273911
12.

Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice.

Selwyn FP, Cheng SL, Bammler TK, Prasad B, Vrana M, Klaassen C, Cui JY.

Toxicol Sci. 2015 Sep;147(1):84-103. doi: 10.1093/toxsci/kfv110. Epub 2015 Jun 1.

13.

Ovulation stimulation protocols utilizing GnRH-antagonist/hCG, promote cytotoxic cell populations, predominant in patients with embryo implantation complications.

Svoboda J, Ruzickova Z, Cuchalova L, Kralickova M, Rezacova J, Vrana M, Fiserova A, Richter J, Madar J.

Neuro Endocrinol Lett. 2013;34(3):249-7.

PMID:
23685425
14.

Class I and III antiarrhythmic drugs for prevention of sudden cardiac death and management of postmyocardial infarction arrhythmias. A review.

Vrana M, Pokorny J, Marcian P, Fejfar Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Jun;157(2):114-24. doi: 10.5507/bp.2013.030. Epub 2013 May 7. Review.

15.

Prevalence of human leukocyte antigen HLA-B*57:01 in HIV-infected subjects in the Czech Republic.

Jilich D, Vraná M, Snopková S, Sedlácek D, Kapla J, Rozsypal H, Kolcáková J, Olbrechtová L, Zjevíková A, Jerhotová Z, Malý M, Stanková M, Machala L.

Cent Eur J Public Health. 2011 Sep;19(3):128-30.

16.
17.

Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective study.

Kaufman JL, Nooka A, Vrana M, Gleason C, Heffner LT, Lonial S.

Cancer. 2010 Jul 1;116(13):3143-51. doi: 10.1002/cncr.25143.

18.

Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donors.

Sedlacek P, Mejstrikova E, Formankova R, Keslova P, Dobrovolna M, Vrana M, Stary J.

Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S10-5. doi: 10.1038/bmt.2008.277. Review.

PMID:
18978735
19.

Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.

Ludajic K, Balavarca Y, Bickeböller H, Pohlreich D, Kouba M, Dobrovolna M, Vrana M, Rosenmayr A, Fischer GF, Fae I, Kalhs P, Greinix HT.

Br J Haematol. 2008 Jul;142(3):436-43. doi: 10.1111/j.1365-2141.2008.07177.x. Epub 2008 Jun 9.

PMID:
18544086
20.

Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen-mismatched unrelated donors.

Sedlacek P, Formankova R, Mejstrikova E, Keslova P, Hubacek P, Dobrovolna M, Vrana M, Kupkova L, Pittrova H, Stary J.

Pediatr Transplant. 2008 Feb;12(1):24-31. doi: 10.1111/j.1399-3046.2007.00762.x.

PMID:
18186885
21.

Matrix metalloproteinase expression in high grade soft tissue sarcomas.

Alford SH, Vrana MS, Waite L, Heim-Hall J, Sylvia VL, Williams RP.

Oncol Rep. 2007 Dec;18(6):1529-36.

PMID:
17982640
22.

[HLA-DPB1 gene analysis in haematopoietic stem cell transplantations].

Vraná M, Dobrovolná M, Cetkovský P, Nazarová S, Vondrácková H, Sedlácek P.

Cas Lek Cesk. 2006;145(2):126-9. Czech.

PMID:
16521401
23.

[Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors].

Dobrovolná M, Vraná M, Brdicka R, Loudová M.

Cas Lek Cesk. 2006;145(1):32-5. Czech.

PMID:
16468239
24.

Sympathetic denervation of the heart in reconstructive surgery of the coronary vessels.

Vrána M, Vránová Z.

Arch Surg. 2004 Aug;139(8):913. No abstract available.

PMID:
15302705
25.

[HLA-DRB1/DQA1/DQB1 alleles and haplotypes in Czech children with celiac sprue].

Kotalová R, Vraná M, Dobrovolná M, Nevoral J, Loudová M.

Cas Lek Cesk. 2002 Aug 16;141(16):518-22. Czech.

PMID:
12404952
26.
27.

The relationship between HA-1 compatibility and the activation of helper T lymphocyte precursors.

Cukrová V, Dobrovolná M, Vraná M, Dolezalová L, Vítek A, Loudová M.

Immunobiology. 2001 May;203(4):699-704.

PMID:
11402503
28.

Prospects for prevention of sudden coronary death.

Fejfar MZ, Vrána M.

Am J Cardiol. 1993 Feb 1;71(4):374-5. No abstract available.

PMID:
8427193
29.

[Variation in the R-R intervals on the electrocardiogram. A new diagnostic method in cardiology].

Vrána M, Fejfar Z, Horák O, Hýza Z, Stupka J, Lánská V.

Cor Vasa. 1993;35(1):32-40. Czech.

PMID:
8444039
30.

[The patient after heart transplantation].

Gebauerová M, Jandová R, Málek I, Pirk J, Stanĕk V, Urbanová D, Vrána M.

Cor Vasa. 1993;35(6):258-62. Czech.

PMID:
8149761
31.
32.

[Directed sympathetic denervation of the heart--an actual therapeutic method or myth?].

Janota M, Vrána M, Vanĕk I, Vránová Z.

Vnitr Lek. 1992 Nov;38(11):1050-5. Czech.

PMID:
1494867
33.

[The effect of mechanical support of the heart on the extent of experimental myocardial necrosis. I].

Táborský J, Vrána M, Horák J, Kolc J.

Rozhl Chir. 1992 Jul;71(7):363-8. Czech.

PMID:
1529384
34.

[Metabolic aspects of hypothermic extracorporeal circulation].

Táborský J, Matĕjcíková M, Schejbalová S, Eserová L, Horká H, Vrána M.

Rozhl Chir. 1992 May;71(5):229-36. Czech.

PMID:
1631752
35.

Heart protection by cardioplegic solutions containing oxyhemoglobin pretreated by carbontetrachloride and freeze-drying with sucrose.

Pristoupil TI, Stĕrbíková J, Vrána M, Havlícková J, Matĕjcková M, Schejbalová S, Eserová L.

Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):709-20.

PMID:
1391500
36.

Analgosedation raises baroreflex sensitivity in acute myocardial ischaemia.

Vrána M, Fejfar Z, Hess L, Blazek Z.

Cor Vasa. 1992;34(5-6):421-7.

PMID:
1339713
37.

A comparison of the protective effect of a modified StTH solution and HTK-B on the energy and functional status of the isolated rat heart.

Chernikov VS, Tutterová M, Bakuleva NP, Vavrínková H, Kostava VT, Vrána M.

Cor Vasa. 1992;34(4):306-13.

PMID:
1308722
38.

[The cardioplegic solution, Plegisol].

Vrána M, Havlícková J, Vavrínková H, Tutterová M, Vránová Z, Matĕjcková M, Schejbalová S, Pristoupil TI, Ulrych S.

Rozhl Chir. 1991 Sep;70(8-9):409-16. Czech. No abstract available.

PMID:
1822642
39.

A method for slowing down depletion of myocardial energy reserves of the donor heart before transplantation.

Vavrínková H, Tutterová M, Vránová Z, Vrána M.

Bratisl Lek Listy. 1991 Mar-Apr;92(3-4):150-4.

PMID:
2029656
40.

[Possibilities of limiting myocardial infarct in an experiment].

Sochman J, Vrána M, Kolc J.

Cas Lek Cesk. 1991 Feb 1;130(5):139-43. Czech.

PMID:
2004404
41.

Analgosedation-enhanced baroreflex sensitivity in acute local myocardial ischaemia.

Vrána M, Fejfar Z, Hess L, Blazek Z.

Cor Vasa. 1991;33(5):428-34.

PMID:
1810704
42.

Prevention of sudden coronary death.

Fejfar Z, Vrána M, Hess L, Vránová Z, Blazek Z.

Czech Med. 1991;14(1):22-34.

PMID:
1676965
43.

[Effects of ethmozine on ventricular fibrillation threshold in acute occlusion of the coronary artery in dogs].

Aniukhovskiĭ EP, Golovina VA, Beloshapko GG, Blazhek Z, Vrana M, Rozenshtraukh LV.

Kardiologiia. 1990 Sep;30(9):73-5. Russian.

PMID:
2273744
44.
45.

Bilirubin and bile acids removal by haemoperfusion through synthetic resin "Persorb".

Filip K, Malý J, Horký J, Tlustáková M, Kálal J, Vrána M.

Czech Med. 1990;13(1):34-7.

PMID:
2350992
46.

[Therapeutic embolization of the venous bed using Vilan 500 in animal experiments].

Janík V, Kolihová E, Peregrin JH, Schlegerová D, Vrána M, Belán A.

Cesk Radiol. 1990 Jan;44(1):44-50. Czech.

PMID:
2344656
47.

[N-acetylcysteine: its effect on myocardial infarct in dogs].

Sochman J, Kolc J, Vrána M, Fabián J.

Cesk Fysiol. 1990;39(6):513-6. Czech. No abstract available.

PMID:
2083443
48.

[Electrical instability of the heart ventricles during focal myocardial ischemia].

Vrána M, Hess L, Vránová Z, Blazek Z, Fejfar Z.

Cesk Fysiol. 1990;39(6):509-12. Czech. No abstract available.

PMID:
2083442
49.

Hemoglobin solutions in experimental cardioplegia.

Pristoupil TI, Vrána M, Havlícková J, Kramlová M.

Int J Artif Organs. 1989 Oct;12(10):668-72.

PMID:
2807594
50.

[The development of ischemic-reperfusion focal injury in the myocardium of the dog 4 to 24 hours after the beginning of ischemia].

Kolc J, Hess L, Kocinová M, Vrána M.

Cesk Fysiol. 1989;38(6):537-9. Czech. No abstract available.

PMID:
2630060

Supplemental Content

Support Center